ConductScience.org, home

Paper41664086

Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study.

Itani M and 8 others. BMC Urol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study. Papers, record 41664086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41664086

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study.
PubMed
Journal
BMC Urol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Itani MMalek
2Livsey TTanner
3Keefer KKellen
4Elghzali AAhmed
5Sherry RRyan
6Harris TTag
7Archer DDaniel
8Ford AIAlicia Ito
9Vassar MMatt

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic HyperplasiaMajor topic
RegistriesMajor topic
Clinical Trials as TopicMajor topic
Male
Humans

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139036761Risks and side effects in the medical management of benign prostatic hyperplasia.Prostate Int2024https://conductscience.org/library/papers/39036761PubMed
217947786Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.BMJ2007https://conductscience.org/library/papers/17947786PubMed
324268083Use of interrupted time series analysis in evaluating health care quality improvements.Acad Pediatr2013https://conductscience.org/library/papers/24268083PubMed
431492792Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications.BMJ Open2019https://conductscience.org/library/papers/31492792PubMed
522433036A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia.BMC Psychiatry2012https://conductscience.org/library/papers/22433036PubMed
637094878CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.BMJ2023https://conductscience.org/library/papers/37094878PubMed
740211463Safety Reporting in Trials on Atrial Fibrillation: An Observational Study of ClinicalTrials.gov Registry and Corresponding Publications.J Cardiovasc Electrophysiol2025https://conductscience.org/library/papers/40211463PubMed
825760355Compliance with results reporting at ClinicalTrials.gov.N Engl J Med2015https://conductscience.org/library/papers/25760355PubMed
919858427Adverse events in randomized trials: neglected, restricted, distorted, and silenced.Arch Intern Med2009https://conductscience.org/library/papers/19858427PubMed
1039915715Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications.BMC Med Res Methodol2025https://conductscience.org/library/papers/39915715PubMed
1115273542Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Ann Surg2004https://conductscience.org/library/papers/15273542PubMed
1227635471Trial Reporting in ClinicalTrials.gov - The Final Rule.N Engl J Med2016https://conductscience.org/library/papers/27635471PubMed
1324311990Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.PLoS Med2013https://conductscience.org/library/papers/24311990PubMed
1424323037Adverse event reporting in cancer clinical trial publications.J Clin Oncol2014https://conductscience.org/library/papers/24323037PubMed
1539533030Safety reporting in trials on glaucoma interventions registered in ClinicalTrials.gov and corresponding publications.Sci Rep2024https://conductscience.org/library/papers/39533030PubMed
1619901971Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.PLoS Med2009https://conductscience.org/library/papers/19901971PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41664086

GET https://conductscience.org/api/papers/v1/41664086/authors